Xiaojia Guo

1.3k total citations
42 papers, 859 citations indexed

About

Xiaojia Guo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaojia Guo has authored 42 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Immunology. Recurrent topics in Xiaojia Guo's work include Microbial metabolism and enzyme function (8 papers), Pancreatitis Pathology and Treatment (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Xiaojia Guo is often cited by papers focused on Microbial metabolism and enzyme function (8 papers), Pancreatitis Pathology and Treatment (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Xiaojia Guo collaborates with scholars based in United States, China and Puerto Rico. Xiaojia Guo's co-authors include Gary V. Désir, Robert Safirstein, Heino Velázquez, Lorraine J. Gudas, Charles Cha, David M. Nanus, John Chang, Ruiyuan Cao, Wu Zhong and Yunzheng Yan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Xiaojia Guo

40 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojia Guo United States 17 495 113 99 82 81 42 859
Jiagao Lv China 17 393 0.8× 105 0.9× 50 0.5× 101 1.2× 96 1.2× 40 1.0k
Ho‐Shik Kim South Korea 20 721 1.5× 184 1.6× 78 0.8× 146 1.8× 170 2.1× 49 1.2k
Lanfeng Wang China 15 385 0.8× 70 0.6× 32 0.3× 72 0.9× 61 0.8× 25 778
Shiyun Wang China 21 543 1.1× 136 1.2× 94 0.9× 62 0.8× 60 0.7× 51 1.3k
Sei‐Hoon Yang South Korea 19 486 1.0× 76 0.7× 138 1.4× 126 1.5× 99 1.2× 42 1.0k
Takanari Nakano Japan 21 412 0.8× 116 1.0× 56 0.6× 69 0.8× 92 1.1× 57 1.1k
Fuu‐Jen Tsai Taiwan 16 295 0.6× 82 0.7× 44 0.4× 83 1.0× 62 0.8× 52 693
Jin Yang China 18 739 1.5× 125 1.1× 80 0.8× 141 1.7× 335 4.1× 56 1.2k
Liyuan Li China 18 629 1.3× 218 1.9× 68 0.7× 172 2.1× 146 1.8× 52 1.2k
Yashang Lee United States 14 429 0.9× 121 1.1× 84 0.8× 102 1.2× 26 0.3× 18 888

Countries citing papers authored by Xiaojia Guo

Since Specialization
Citations

This map shows the geographic impact of Xiaojia Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojia Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojia Guo more than expected).

Fields of papers citing papers by Xiaojia Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojia Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojia Guo. The network helps show where Xiaojia Guo may publish in the future.

Co-authorship network of co-authors of Xiaojia Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojia Guo. A scholar is included among the top collaborators of Xiaojia Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojia Guo. Xiaojia Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Xiaojia, et al.. (2024). Ent-atisane diterpenoids from Euphorbia wallichii and their anti-influenza A virus activity. Phytochemistry. 220. 113996–113996. 5 indexed citations
3.
Yang, Liu, Xiaojia Guo, Wen Zhou, et al.. (2024). Prognostic significance of CRLF2 in patients with acute lymphoblastic leukemia: a meta-analysis and systematic review. Annals of Hematology. 103(11). 4413–4425. 1 indexed citations
4.
Guo, Xiaojia, et al.. (2024). The Synergistic Effect of Baloxavir and Neuraminidase Inhibitors against Influenza Viruses In Vitro. Viruses. 16(9). 1467–1467. 1 indexed citations
5.
Guo, Xiaojia, Valérie Blanc, Nicholas O. Davidson, et al.. (2023). APOBEC-1 deletion enhances cisplatin-induced acute kidney injury. Scientific Reports. 13(1). 22255–22255. 1 indexed citations
6.
Wang, Zhuang, Yunzheng Yan, Ji‐Ye Yin, et al.. (2022). Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp. Viruses. 14(6). 1228–1228. 4 indexed citations
7.
Li, Yuexiang, Miao Liu, Yunzheng Yan, et al.. (2022). Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo. Viruses. 14(6). 1142–1142. 15 indexed citations
8.
Yan, Yunzheng, Zihao Wang, Ji‐Ye Yin, et al.. (2022). The CDK1 inhibitor, Ro-3306, is a potential antiviral candidate against influenza virus infection. Antiviral Research. 201. 105296–105296. 7 indexed citations
9.
Safdar, Basmah, Melinda Wang, Xiaojia Guo, et al.. (2022). Association of renalase with clinical outcomes in hospitalized patients with COVID-19. PLoS ONE. 17(3). e0264178–e0264178. 3 indexed citations
10.
Wang, Melinda, Xiaojia Guo, Jill Lacy, et al.. (2021). Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma. PLoS ONE. 16(9). e0250539–e0250539. 6 indexed citations
11.
Zhang, Liansheng, et al.. (2021). Aggressive natural killer cell leukemia with skin manifestation associated with hemophagocytic lymphohistiocytosis: a case report. World Journal of Clinical Cases. 9(34). 10708–10714.
12.
Cao, Ruiyuan, Hengrui Hu, Yufeng Li, et al.. (2020). Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. ACS Infectious Diseases. 6(9). 2524–2531. 117 indexed citations
13.
Guo, Xiaojia, Heino Velázquez, Richard Torres, et al.. (2019). Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease. Kidney International. 95(4). 797–814. 66 indexed citations
14.
Safdar, Basmah, Xiaojia Guo, Gail D’Onofrio, et al.. (2019). Elevated renalase levels in patients with acute coronary microvascular dysfunction – A possible biomarker for ischemia. International Journal of Cardiology. 279. 155–161. 22 indexed citations
15.
Guo, Xiaojia, Heino Velázquez, John Chang, et al.. (2016). Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism. Cancer Research. 76(13). 3884–3894. 45 indexed citations
16.
Guo, Xiaojia, Douglas MacPherson, Ling Wang, et al.. (2016). Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer. Scientific Reports. 6(1). 22996–22996. 35 indexed citations
17.
Guo, Xiaojia, Ling Wang, Heino Velázquez, Robert Safirstein, & Gary V. Désir. (2014). Renalase. Current Opinion in Nephrology & Hypertension. 23(5). 513–518. 46 indexed citations
18.
Nicholson, Allen D., Xiaojia Guo, Catherine Sullivan, & Charles Cha. (2014). Automated Quantitative Analysis of Tissue Microarray of 443 Patients with Colorectal Adenocarcinoma: Low Expression of Bcl-2 Predicts Poor Survival. Journal of the American College of Surgeons. 219(5). 977–987. 4 indexed citations
19.
Guo, Xiaojia, John C. Schmitz, Barton Kenney, et al.. (2012). Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival. Cancer Science. 103(8). 1474–1480. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiagao Lv Breakdown of academic impact, for papers by Ho‐Shik Kim Breakdown of academic impact, for papers by Lanfeng Wang Breakdown of academic impact, for papers by Shiyun Wang Breakdown of academic impact, for papers by Sei‐Hoon Yang Breakdown of academic impact, for papers by Takanari Nakano Breakdown of academic impact, for papers by Fuu‐Jen Tsai Breakdown of academic impact, for papers by Jin Yang Breakdown of academic impact, for papers by Liyuan Li Breakdown of academic impact, for papers by Yashang Lee
Rankless by CCL
2026